Key result
Furosemide, glibenclamide, and DIDS inhibited ATP-activated Cl- current in a concentration-dependent manner with maximal inhibition of 88±4%, 93±1%, and 79±3%, respectively.
ATP-induced Ca2+ entry activates Ca2+-activated Cl- channels which mediate NO release from endothelial cells.
Answers are grounded in this paper and cite their sources.
May blunt endothelial NO release in animal models; hypothesis-generating for vascular effects, should not change practice.
Patch‐clamp whole‐cell recording techniques were used to study ATP‐induced Cl‐ current and the effects of Cl‐ channel blockers on NO release in bovine aortic endothelial cells. ATP evoked an outward rectified Cl‐ current with a reversal potential of −29±3 mV. This outward rectified Cl‐ current was dependent on Ca2+ influx, but not Ca2+ release. In Ca2+‐free medium, ATP did not produce the Cl‐ current; however, subsequent addition of Ca2+ to the medium evoked an ATP‐induced outward rectified Cl‐ current. Furosemide, glibenclamide, and DIDS inhibited ATP‐activated Cl‐ current in a concentration‐dependent manner with maximal inhibition of 88±4%, 93±1%, and 79±3%, respectively. The IC50 values of furosemide, glibenclamide, and DIDS were 6.2±2.6, 29.6±12.3, and 21.0±13.4 µM, respectively. These effects of Cl‐ channel blockers matched those on NO release from endothelial cells. Our data suggest that ATP‐induced Ca2+ entry followed by increased [Ca2+]i activates Ca2+‐activated Cl‐ channels which mediate NO release from endothelial cells. Drug Dev. Res. 58:53–56, 2003.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2003) studied this question. ATP and Cl- channel blockers (Furosemide, glibenclamide, DIDS) was evaluated on ATP-induced Cl- current and NO release. Furosemide, glibenclamide, and DIDS inhibited ATP-activated Cl- current in a concentration-dependent manner with maximal inhibition of 88±4%, 93±1%, and 79±3%, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: